Sumitomo Mitsui DS Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,841
Closed -$2.54M 768
2021
Q2
$2.54M Sell
13,841
-107
-0.8% -$18.4K 0.06% 277
2021
Q1
$2.13M Buy
13,948
+31
+0.2% +$4.79K 0.06% 296
2020
Q4
$2.17M Sell
13,917
-29
-0.2% -$3.73K 0.06% 275
2020
Q3
$1.59M Buy
13,946
+222
+2% +$23.9K 0.05% 307
2020
Q2
$1.54M Buy
13,724
+730
+6% +$77.5K 0.05% 292
2020
Q1
$1.17M Sell
12,994
-822
-6% -$80.7K 0.05% 314
2019
Q4
$1.49M Sell
13,816
-44
-0.3% -$4.71K 0.05% 321
2019
Q3
$1.36M Buy
13,860
+1,927
+16% +$217K 0.05% 327
2019
Q2
$1.56M Sell
11,933
-3,349
-22% -$432K 0.06% 277
2019
Q1
$2.06M Buy
15,282
+714
+5% +$88.8K 0.03% 350
2018
Q4
$1.42M Sell
14,568
-829
-5% -$98K 0.03% 382
2018
Q3
$2.14M Sell
15,397
-117
-0.8% -$14.7K 0.03% 347
2018
Q2
$1.93M Buy
15,514
+230
+2% +$26.9K 0.03% 366
2018
Q1
$1.7M Sell
15,284
-993
-6% -$119K 0.03% 398
2017
Q4
$1.95M Sell
16,277
-1,045
-6% -$127K 0.03% 372
2017
Q3
$2.43M Sell
17,322
-685
-4% -$93.1K 0.04% 309
2017
Q2
$2.19M Sell
18,007
-852
-5% -$99.2K 0.04% 330
2017
Q1
$2.29M Buy
18,859
+1,849
+11% +$238K 0.04% 319
2016
Q4
$2.08M Sell
17,010
-186
-1% -$22.8K 0.04% 313
2016
Q3
$2.11M Sell
17,196
-45
-0.3% -$5.79K 0.05% 300
2016
Q2
$2.01M Buy
17,241
+232
+1% +$32.9K 0.06% 264
2016
Q1
$2.37M Buy
17,009
+542
+3% +$79.6K 0.07% 232
2015
Q4
$3.14M Sell
16,467
-366
-2% -$63.9K 0.11% 191
2015
Q3
$2.63M Buy
16,833
+1,236
+8% +$225K 0.09% 211
2015
Q2
$2.82M Sell
15,597
-132
-0.8% -$22.8K 0.09% 221
2015
Q1
$2.73M Sell
15,729
-1,171
-7% -$212K 0.08% 231
2014
Q4
$3.13M Sell
16,900
-1,504
-8% -$279K 0.1% 209
2014
Q3
$3.05M Sell
18,404
-1,088
-6% -$179K 0.09% 218
2014
Q2
$3.04M Sell
19,492
-1,073
-5% -$169K 0.09% 236
2014
Q1
$3.13M Sell
20,565
-1,348
-6% -$214K 0.09% 209
2013
Q4
$2.92M Sell
21,913
-1,505
-6% -$181K 0.08% 221
2013
Q3
$2.72M Sell
23,418
-1,231
-5% -$135K 0.08% 232
2013
Q2
$2.27M Buy
+24,649
New +$2.38M 0.06% 269

Other funds holding ALXN